Stay updated on Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added a 'Study Results' section with voluntary publications about the study results. Removed generic 'General' content and some regulatory labels.
    Difference
    0.2%
    Check dated 2026-04-09T08:12:24.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:12:07.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.4.3 has been added, and the old Revision: v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:28:19.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 and prior government funding notices removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:27:52.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status and NIH Clinical Center operations has been added, and the page revision updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T01:22:27.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Added: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; removed/changed: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T00:17:33.000Z thumbnail image

Stay in the know with updates to Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial page.